Arjaans M,Oude Munnink TH,Oosting SF,Terwisscha van Scheltinga AG,Gietema JA,Garbacik ET,Timmer-Bosscha H,Lub-de Hooge MN,Schröder CP,de Vries EG CP .2013 .Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake. Cancer Res, 73(11) : 3347-55.
Choi AH,Kim J,Chao J .2015 .Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond. World J. Gastroenterol., 21(24) : 7343-8.
De Sol A,Cirocchi R,Di Patrizi MS,Boccolini A,Barillaro I,Cacurri A,Grassi V,Corsi A,Renzi C,Giuliani D,Coccetta M,Avenia N M .2015 .The measurement of amylase in drain fluid for the detection of pancreatic fistula after gastric cancer surgery: An interim analysis. World J. Surg, 19(13) : 65.
Guggenheim DE and Shah MA .2013 .Gastric cancer epidemiology and risk factors. J. Surg, 107(3) : 230-236.
Johnson K,Gomez A,Burton J,White D,Chakravarty A,Schmid A,Bottino D A .2019 .Directional inconsistency between response evaluation criteria in solid tumors (RECIST) time to progression and response speed and depth. Eur. J. Cance., 109 : 196-203.
Khan U,Shah MA U .2019 .Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer. Expert. Opin. Biol. Ther, 19(11) : 1135-1141.
Kulig P,Sierzega M,Pietruszka S,Pach R,Kołodziejczyk P,Kulig J,Richter P .2020 .Types and implications of abdominal fluid collections following gastric cancer surgery. Acta. Chir, 120(5) : 315-320.
Lerut T,Moons J,Coosemans W,Van Raemdonck D,De Leyn P,Decaluwé H,Decker G,Nafteux P .2009 .Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastro esophageal junction are correlated with early cancer recurrence: Role of systematic grading of complications using the modified Clavien classification. , 250(5) : 798-807.
Li F,Liao Z,Zhang C,Zhao J,Xing R,Teng S,Zhang J,Yang Y,Yang J .2018 .Apatinib as targeted therapy for sarcoma. Oncotarget, 9(36) : 24548-24560.
Li K,Shi M,Qin S M .2018 .Current status and study progress of recombinant human endostatin in cancer treatment. Oncol. The., 6(1) : 21-43.
Li Q,Xu X,Su D,Zhou T,Wang G,Li Z G .2019 .Long-term survival of an elderly patient with advanced gastric cancer after combination therapy: A case report and literature review. BMC Cancer, 19(1) : 459.
Liu Y,Tu L,Wang L,Long J,Wang J,Wang Y,Luo F,Cao D F .2016 .The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer. Onco. Targets. Ther., 9 : 6581-6595.
Mawalla B,Yuan X,Luo X,Chalya PL .2018 .Treatment outcome of anti-angiogenesis through VEGF-pathway in the management of gastric cancer: a systematic review of phase II and III clinical trials. BMC Res Notes, 11(1) : 21.
Ohtsu A,Shah MA,Van Cutsem E,Rha SY,Sawaki A,Park SR,Lim HY,Yamada Y,Wu J,Langer B,Starnawski M,Kang YK M .2011 .Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A randomized, double-blind, placebo-controlled phase III study. J. Clin. Oncol., 29(30) : 3968-76.
Ono H,Yao K,Fujishiro M,Oda I,Nimura S,Yahagi N,Iishi H,Oka M,Ajioka Y,Ichinose M,Matsui T .2016 .Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig. Endosc, 28(1) : 3-15.
Pellino A,Riello E,Nappo F,Brignola S,Murgioni S,Djaballah SA,Lonardi S,Zagonel V,Rugge M,Loupakis F,Fassan M .2019 .Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives. World J. Gastroenterol., 25(38) : 5773-5788.
Roviello G,Ravelli A,Fiaschi AI,Cappelletti MR,Gobbi A,Senti C,Zanotti L,Polom K,Reynolds AR,Fox SB,Generali D SB .2016 .Apatinib for the treatment of gastric cancer. Expert Rev. Gastroenterol. Hepatol., 10(8) : 887-92.
Yamaguchi T,Fushida S,Yamamoto Y,Tsukada T,Kinoshita J,Oyama K,Miyashita T,Tajima H,Ninomiya I,Munesue S,Harashima A,Harada S,Yamamoto H,Ohta T H .2016 .Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination. Gastric Cancer, 19(4) : 1052-1065.
Zou G,Zhang X,Wang L,Li X,Xie T,Zhao J,Yan J,Wang L,Ye H,Jiao S,Xiang R,Shi Y .2020 .Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. Theranostics, 10(15) : 6839-6853.